Daewoong Pharma
KRX:069620
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
113 000
193 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
Price Targets Summary
Daewoong Pharma
According to Wall Street analysts, the average 1-year price target for
Daewoong Pharma
is 215 475 KRW
with a low forecast of 181 800 KRW and a high forecast of 262 500 KRW.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Daewoong Pharma's stock price target?
Price Target
215 475
KRW
According to Wall Street analysts, the average 1-year price target for
Daewoong Pharma
is 215 475 KRW
with a low forecast of 181 800 KRW and a high forecast of 262 500 KRW.
What is Daewoong Pharma's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Daewoong Pharma's revenue is
5%.
The projected
CAGR
for the next 3 years is
9%.
What is Daewoong Pharma's Operating Income forecast?
Projected CAGR
21%
For the last 13 years the
compound annual growth rate for
Daewoong Pharma's operating income is
7%.
The projected
CAGR
for the next 3 years is
21%.
What is Daewoong Pharma's Net Income forecast?
Projected CAGR
102%
For the last 13 years the
compound annual growth rate for
Daewoong Pharma's net income is
-5%.
The projected
CAGR
for the next 3 years is
102%.
